Monopar Therapeutics (MNPR) Earnings Date, Estimates & Call Transcripts $16.93 -15.73 (-48.16%) (As of 10/25/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateNov. 14EstimatedActual EPS (Aug. 9) -$0.10 Missed By -$0.01 Consensus EPS (Aug. 9) -$0.09 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMNPR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MNPR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad 10 Minute TradesNewton is finally here!After Roger, one of the first guys I worked with behind the scenes here is Graham. I’ve been really impressed by some of what he’s come up with! But his brand new Newton indicator might take the cake. It’s one of the easiest “buy/sell” tools I’ve ever seen. Just buy when it lights up green, and sell when it goes red. Graham recently identified three NEW potential breakout stocks using Newton, and he’s sharing them in a FREE video.Just sign up here to learn more - we are having a live demo on Monday Monopar Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.20)($0.17)($0.19)Q2 20242($0.17)($0.14)($0.16)Q3 20242($2.60)($0.19)($1.40)Q4 20242($2.70)($0.41)($1.56)FY 20248($5.67)($0.91)($3.29)Q1 20251($2.75)($2.75)($2.75)Q2 20251($2.80)($2.80)($2.80)Q3 20251($2.85)($2.85)($2.85)Q4 20251($1.50)($1.50)($1.50)FY 20254($9.90)($9.90)($9.90)MNPR Earnings Date and InformationMonopar Therapeutics last released its earnings data on August 9th, 2024. The reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.09) by $0.01. Monopar Therapeutics has generated ($0.52) earnings per share over the last year (($0.52) diluted earnings per share). Earnings for Monopar Therapeutics are expected to grow in the coming year, from ($1.93) to ($1.82) per share. Monopar Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off prior year's report dates.Read More Monopar Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/14/2024(Estimated)------- 8/9/2024-($0.09)($0.10)($0.01)($0.10)--5/9/2024Q1 2024($0.85)($0.50)+$0.35($0.10)--3/28/2024Q4 2023($0.85)($0.60)+$0.25($0.12)--11/9/2023Q3 2023($0.95)($0.70)+$0.25($0.14)--8/10/2023Q2 2023($0.95)($0.80)+$0.15($0.16)--5/11/2023Q1 2023($1.00)($0.95)+$0.05($0.19)--Newton is finally here! (Ad)After Roger, one of the first guys I worked with behind the scenes here is Graham. I’ve been really impressed by some of what he’s come up with! But his brand new Newton indicator might take the cake. It’s one of the easiest “buy/sell” tools I’ve ever seen. Just buy when it lights up green, and sell when it goes red. Graham recently identified three NEW potential breakout stocks using Newton, and he’s sharing them in a FREE video.Just sign up here to learn more - we are having a live demo on Monday3/23/2023Q4 2022($1.05)($1.10)($0.05)($0.22)--11/10/2022Q3 2022($1.15)($0.95)+$0.20($0.19)--8/11/2022Q2 2022($1.05)($1.10)($0.05)($0.22)--5/12/2022Q1 2022($1.20)($0.95)+$0.25($0.19)--3/24/2022Q4 2021($0.90)($1.05)($0.15)($0.21)--11/12/2021Q3($1.10)($1.00)+$0.10($0.20)--8/12/2021Q2($0.9650)($0.85)+$0.1150($0.17)--5/13/2021Q1($0.9350)($0.80)+$0.1350($0.16)--3/24/2021Q4($1.0150)($0.90)+$0.1150($0.19)--11/12/2020Q3 2020($0.75)($1.35)($0.60)($0.27)-$0.14 million8/6/2020Q2 2020($1.25)($0.70)+$0.55($0.14)--5/7/2020Q1 2020($0.55)($0.50)+$0.05($0.10)--3/27/2020Q4 2019($0.35)($0.65)($0.30)($0.13)-- Monopar Therapeutics Earnings - Frequently Asked Questions When is Monopar Therapeutics's earnings date? Monopar Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on MNPR's earnings history. Did Monopar Therapeutics beat their earnings estimates last quarter? In the previous quarter, Monopar Therapeutics (NASDAQ:MNPR) missed the analysts' consensus estimate of ($0.09) by $0.01 with a reported earnings per share (EPS) of ($0.10). Learn more on analysts' earnings estimate vs. MNPR's actual earnings. How much profit does Monopar Therapeutics generate each year? Monopar Therapeutics (NASDAQ:MNPR) has a recorded net income of -$8.40 million. MNPR has generated -$0.52 earnings per share over the last four quarters. What is Monopar Therapeutics's EPS forecast for next year? Monopar Therapeutics's earnings are expected to grow from ($1.93) per share to ($1.82) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies VTGN Earnings Results CTXR Earnings Results DARE Earnings Results EDSA Earnings Results MACK Earnings Results GTHX Earnings Results CYRX Earnings Results FATE Earnings Results LXEO Earnings Results ZVRA Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles PulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to Trouble This page (NASDAQ:MNPR) was last updated on 10/25/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | Sponsored“Hear That Whoosh Sound? It’s the Great Power Suck of 2025”We’re coming to the end of the line for the traditional energy grid. Look what’s happening in California.Traders Agency | SponsoredInvest in the company that won over the DragonsThe pioneer in smart-doorbell technology, RING, pitched their business on the hit show Shark Tank at a valuati...RYSE | SponsoredPutin proposes new currencyRussian leader Vladimir Putin just unveiled the first physical mockup of a proposed new currency. Many spec...Stansberry Research | SponsoredONE crypto stock +526% in under 60 daysCryptos are screaming higher right now. Yet, this ONE started a shooting up a little under 60 days ago.The Bitcoin Capitalist | SponsoredAs much as 750,000 homesAmerica is running out of power … Vast sections of the United States — and the world — are facing an impend...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Monopar Therapeutics Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Monopar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
